Robert L. Roden - Concepedia

Author

Robert L. Roden

University of Colorado Health

Also Known As

R L Roden, R Roden, R. L. Roden, R. Roden, R.L. Roden, Robert L Roden, Robert L. Roden, Robert Roden

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Health University of Colorado Denver University of Utah

About

Robert L. Roden is an author at University of Colorado Health specializing in medicine, cardiology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.6K
2	Health Sciences	3	3	684
3	Applied Physiology	1	1	59
4	Exercise Physiology	1	1	59
5	Neuroscience	1	1	33

Robert L. Roden

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. Brian D. Lowes, Wayne Minobe, William T. Abraham, Journal of Clinical Investigation Cardiac MuscleHeart FailureGeneticsIdc RvsDiastolic Function	1997	501
Increased Protein Kinase C Activity and Expression of Ca <sup>2+</sup> -Sensitive Isoforms in the Failing Human Heart Nancy Bowling, Richard A. Walsh, Guojie Song, Circulation	1999	453
Myosin heavy chain gene expression in human heart failure. Kōichi Nakao, Wayne Minobe, Robert L. Roden, Journal of Clinical Investigation Cardiac MuscleHuman Heart FailureHeart FailureMolecular PhysiologyTransplantation	1997	415
Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Michel White, Robert L. Roden, Wayne Minobe, Circulation	1994	287
Myocardial-Directed Overexpression of the Human β1-Adrenergic Receptor in Transgenic Mice John D. Bisognano, Howard D. Weinberger, Teresa Bohlmeyer, Journal of Molecular and Cellular Cardiology Molecular PharmacologyCardiac MuscleMolecular PhysiologyHuman β1-Adrenergic ReceptorMedicine	2000	262
Selective Downregulation of the Angiotensin II AT<sub>1</sub>-Receptor Subtype in Failing Human Ventricular Myocardium Koji Asano, Darrin Dutcher, J. David Port, Circulation	1997	167
Cardiac β-Adrenergic Neuroeffector Systems in Acute Myocardial Dysfunction Related to Brain Injury Michel White, Robert J. Wiechmann, Robert L. Roden, Circulation	1995	156
Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway. Lawrence S. Zisman, William T. Abraham, Glenn E. Meixell, Journal of Clinical Investigation Ang Ii FormationCardiac MuscleHypertensionHeart FailureCardiovascular Pharmacology	1995	124
Efficacy and Safety of Darusentan in Patients With Resistant Hypertension: Results From a Randomized, Double‐Blind, Placebo‐Controlled Dose‐Ranging Study Henry R. Black, George L. Bakris, Michael A. Weber, Journal of Clinical Hypertension Molecular PharmacologyHypertensionResistant HypertensionDose‐ranging StudyCardiovascular Disease	2007	106
Coordinate Changes in Myosin Heavy Chain Isoform Gene Expression Are Selectively Associated With Alterations in Dilated Cardiomyopathy Phenotype William T. Abraham, Edward M. Gilbert, Brian D. Lowes, Molecular Medicine	2002	105

Page 1